Estimates of incidence density and respective 95% confidence interval of number of (A) all cSCC, (B) cSCC in scalp, head and neck, (C) cSCC moderately differentiated, and (D) cSCC poorly differentiated over time, stratified by sirolimus (blue) or control (orange) study groups.
head and neck lesions
When stratified by each one of the high-risk criteria, a trend of decreasing incidence density in favor of the sirolimus group was observed in scalp, head and neck lesions over time (